1)内視鏡外科手術に関するアンケート調査 第9回集計結果報告.日鏡外会誌 13:526,2008
2)Sasako M, Sano T, Yamamoto S, et al:Randomized phase Ⅲ trial of standard D2 versus D2+para-aortic lymph node(PAN)dissection(D)for clinically M0 advanced gastric cancer;JCOG9501. J Clin Oncol 24(18s):LBA4015, 2006
3)Bonenkamp JJ, Hermans J, Sasako M, et al:Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908-914, 1999
4)Sano T, Sasako M, Yamamoto S, et al:Gastric cancer surgery:morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol 22:2767-2773, 2004
5)Cuschieri A, Weeden S, Fielding J, et al:Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical tiral. Br J Cancer 79:1522-1530, 1999
6)Bonenkamp JJ, Songun I, Hermans J, et al:Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745-748, 1995
7)Degiuli M, Sasako M, Ponti A, et al:Survival results of a multicentre phase Ⅱ study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90:1727-1732, 2004
8)Cunningham D, Allum WH, Stenning SP, et al:Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006a
9)Wanebo HJ, Kennedy BJ, Chmiel J, et al:Cancer of the stomach. A patient care study by the American College of Surgeons. Am J Surg 218:583-592, 1993
10)Siewert JR, Böttcher K, Roder JD, et al:Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Cancer 80:1015-1018, 1993
11)Pacelli F, Doglietto GB, Bellantone R, et al:Extensive versus limited lymph node dissection for gastric cancer:a comparative study of 320 patients. Br J Surg 80:1153-1156, 1993